These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35686666)

  • 21. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.
    Liu G; Xu X; Yi Q; Lv T
    J Interv Card Electrophysiol; 2021 Sep; 61(3):435-443. PubMed ID: 33723693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained Ventricular Tachycardia in Apparently Normal Hearts: Ablation Should Be the First Step in Management.
    Moss JD; Tung R
    Card Electrophysiol Clin; 2016 Sep; 8(3):623-30. PubMed ID: 27521095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.
    Pitschner HF; Neuzner J; Himmrich E; Liebrich A; Jung J; Heisel A
    J Interv Card Electrophysiol; 1997 Nov; 1(3):211-20. PubMed ID: 9869974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Timing of VT Ablation for Patients with ICD Therapies.
    Radinovic A; Baratto F; Della Bella P
    Curr Cardiol Rep; 2020 Jul; 22(9):91. PubMed ID: 32648057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis.
    Delacrétaz E; Brenner R; Schaumann A; Eckardt L; Willems S; Pitschner HF; Kautzner J; Schumacher B; Hansen PS; Kuck KH;
    J Cardiovasc Electrophysiol; 2013 May; 24(5):525-9. PubMed ID: 23350967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.
    Briceño DF; Romero J; Patel K; Liaqat W; Zhang XD; Alviz I; Yang R; Rodriguez D; Lakkireddy D; Rocca DD; Tarantino N; Gopinathannair R; Natale A; Di Biase L
    J Interv Card Electrophysiol; 2021 Nov; 62(2):391-400. PubMed ID: 33179155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant.
    Penela D; Acosta J; Aguinaga L; Tercedor L; Ordoñez A; Fernández-Armenta J; Andreu D; Sánchez-Millán PJ; Cabanelas N; Tolosana JM; Vassanelli F; Cabrera M; Korshunov V; Sitges M; Brugada J; Mont L; Berruezo A
    Heart Rhythm; 2015 Dec; 12(12):2434-42. PubMed ID: 26385530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of BERLIN VT study: a multicenter randomised trial comparing preventive versus deferred ablation of ventricular tachycardia.
    Tilz RR; Kuck KH; Kääb S; Wegscheider K; Thiem A; Wenzel B; Willems S; Steven D
    BMJ Open; 2019 May; 9(5):e022910. PubMed ID: 31072848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Case report and review about radiofrequency catheter ablation in a patient with dilated cardiomyopathy and an implantable cardioverter defibrillator].
    Lepillier A; Paziaud O; Lascault G; Copie X; Piot O
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):34-9. PubMed ID: 18667195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
    J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.